0001493152-19-008568.txt : 20190603 0001493152-19-008568.hdr.sgml : 20190603 20190603170011 ACCESSION NUMBER: 0001493152-19-008568 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190531 FILED AS OF DATE: 20190603 DATE AS OF CHANGE: 20190603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STERN ADAM K CENTRAL INDEX KEY: 0001403497 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38022 FILM NUMBER: 19873961 MAIL ADDRESS: STREET 1: STERN AEGIS VENTURES STREET 2: 810 7TH AVENUE 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Matinas BioPharma Holdings, Inc. CENTRAL INDEX KEY: 0001582554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463011414 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1545 ROUTE 206 SOUTH STREET 2: SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: 908-443-1860 MAIL ADDRESS: STREET 1: 1545 ROUTE 206 SOUTH STREET 2: SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 ownership.xml X0306 4 2019-05-31 0 0001582554 Matinas BioPharma Holdings, Inc. MTNB 0001403497 STERN ADAM K AEGIS CAPITAL CORP, ATTN: CASSEL SHAPIRO 810 SEVENTH AVE., 18TH FLOOR NEW YORK NY 10019 1 0 0 0 Common Stock, par value $0.0001 per share 2019-05-31 4 P 0 80000 0.94 A 3169483 I Held by AKS Family Partners LP Common Stock, par value $0.0001 per share 793992 D Common Stock, par value $0.0001 per share 300000 I Held by Pavilion Capital Partners Inc. Common Stock, par value $0.0001 per share 300000 I Held by Piper Ventures Partners LLC Common Stock, par value $0.0001 per share 1750000 I Held by AKS Family Foundation, Inc. Common Stock, par value $0.0001 per share 600000 I Held by SternAegis Ventures LLC Defined Benefit Pension Plan Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose. The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.92 to $0.95, inclusive. The reporting person undertakes to provide to Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. /s/ Jerome D. Jabbour, attorney-in fact for Adam K. Stern 2019-06-03